Tropical diseases

Worldwide Dengue Vaccine Industry to 2025 - Key Drivers, Challenges and Trends - ResearchAndMarkets.com

Retrieved on: 
Monday, June 21, 2021
Infectious diseases, Pharmaceutical, Health, Medical specialties, Infectious diseases, Clinical medicine, Dengue fever, Vaccines, Tropical diseases, Dengue vaccine, Vaccine

The publisher has been monitoring the dengue vaccine market and it is poised to grow by $132.90 million during 2021-2025, progressing at a CAGR of about 18% during the forecast period.

Key Points: 
  • The publisher has been monitoring the dengue vaccine market and it is poised to grow by $132.90 million during 2021-2025, progressing at a CAGR of about 18% during the forecast period.
  • This report on the dengue vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • The dengue vaccine market analysis includes the end-user segment and geographic landscape.
  • This study identifies the initiatives for dengue vaccine research and dengue immunization programs as one of the prime reasons driving the dengue vaccine market growth during the next few years.

Villya Pharmaceuticals Announces Patent Approval for 2 New Drugs to Treat FGS

Retrieved on: 
Tuesday, June 15, 2021
Medical specialties, Infectious diseases, Clinical medicine, Tropical diseases, Helminthiases, Waterborne diseases, Infectious causes of cancer, Neglected tropical diseases, Schistosomiasis, Schistosoma haematobium, Infection, HIV

Up to 50% of the women having Schistosomiasis haematobium suffer from female genital schistosomiasisor FGS.

Key Points: 
  • Up to 50% of the women having Schistosomiasis haematobium suffer from female genital schistosomiasisor FGS.
  • Though the greatest risk is the open lesions caused by FGS that leave the subject susceptible to HIV and other infections.
  • William Miller, CEO at Villya Pharmaceuticals says "FGS is a neglected tropical disease for which there was no specific treatment until now.
  • Miller continued by saying "Villya designed these two new drugs specifically to eliminate this disease.

MedinCell’s Long-Acting Injectable to Fight Malaria Ready to Enter Regulatory Development

Retrieved on: 
Monday, June 14, 2021
Health, Infectious diseases, Clinical trials, Research, Science, Pharmaceutical, Biotechnology, Infectious diseases, Drugs, Medical specialties, Tropical diseases, Malaria, Ivermectin, Mosquito net, Mosquito

The investigational product mdc-STM aims at reducing the transmission of the parasite responsible for Malaria, thanks to a killing effect on the vector mosquitoes when they bite treated people.

Key Points: 
  • The investigational product mdc-STM aims at reducing the transmission of the parasite responsible for Malaria, thanks to a killing effect on the vector mosquitoes when they bite treated people.
  • Malaria remains one of the main health threats worldwide with more than 200 million people infected yearly.
  • mdc-STM benefits from synergies with other MedinCells programs based on Ivermectin all of them using different formulation and doses fitted to their specific indications.
  • compliance with medical prescriptions, and to a significant reduction in the quantity of medication required as part of a one-off or chronic treatment.

Freshpet Voluntarily Recalls One Lot of Freshpet® Select Small Dog Bite Size Beef & Egg Recipe Dog Food Due to Potential Salmonella Contamination

Retrieved on: 
Saturday, June 12, 2021
Infectious diseases, Medical specialties, Neglected tropical diseases, Tropical diseases, Clinical medicine, Gram-negative bacteria, Pathogenic bacteria, Salmonella, Zoonoses

BETHLEHAM, Pa., June 12, 2021 /PRNewswire/ --Freshpet Inc. is announcing a voluntary recall ofa single lot ofFreshpet SelectSmallDogBiteSizeBeef&EggRecipe Dog Food (1 LB bags), with Sell by Date 10/30/2021, due to potential contamination with Salmonella.

Key Points: 
  • BETHLEHAM, Pa., June 12, 2021 /PRNewswire/ --Freshpet Inc. is announcing a voluntary recall ofa single lot ofFreshpet SelectSmallDogBiteSizeBeef&EggRecipe Dog Food (1 LB bags), with Sell by Date 10/30/2021, due to potential contamination with Salmonella.
  • Our Freshpet Team had designated this single lot for destruction, but it was inadvertently shipped to retailers in limited geographic markets between June 7 and June 10, 2021.
  • Rarely,Salmonellacan result in more serious ailments, including arterial infections, endocarditis, arthritis, muscle pain, eye irritation, and urinary tract symptoms.
  • Sell by Date, along with UPC code and lot code, can be found on the bottom and back of each bag.

Global Neglected Tropical Diseases Diagnosis Market Research Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Friday, June 11, 2021
Pharmaceutical, Health, Medical devices, Tropical diseases, Medical specialties, Neglected tropical diseases, Sanitation, Medicine, Clinical medicine

The "Neglected Tropical Diseases Diagnosis - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Neglected Tropical Diseases Diagnosis - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Neglected Tropical Diseases Diagnosis estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$7.9 Billion by 2027, growing at a CAGR of 4% over the period 2020-2027.
  • Conventional, one of the segments analyzed in the report, is projected to record 3.7% CAGR and reach US$4.4 Billion by the end of the analysis period.
  • The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 6.4% CAGR
    The Neglected Tropical Diseases Diagnosis market in the U.S. is estimated at US$1.6 Billion in the year 2020.

Auransa and POLARISqb enter research collaboration finding treatments for neglected women's diseases

Retrieved on: 
Friday, June 4, 2021
Tropical diseases, Medical specialties, Neglected tropical diseases, Sanitation, Neglected diseases, Medicine, Clinical medicine

The partnership seeks to discover treatments that may tackle many such diseases, and their complementary expertise promises to seek solutions that elude medical research.

Key Points: 
  • The partnership seeks to discover treatments that may tackle many such diseases, and their complementary expertise promises to seek solutions that elude medical research.
  • Auransa is an AI-driven biotech company, with a pipeline of novel compounds for various diseases.
  • POLARISqb built the first drug discovery platform using quantum computing, making the process ten times faster.
  • We are thrilled to be able to combine our technology with Auransa's and tackle neglected diseases affecting women.

Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update, Confirming Safety and Effectiveness in Children

Retrieved on: 
Wednesday, June 2, 2021
Medical specialties, Infectious diseases, Clinical medicine, Kamada, Rehovot, Science and technology in Israel, Neglected tropical diseases, Tropical diseases, Rabies

"As the U.S. market's first and only human rabies immune globulin to be studied in children, KEDRAB is an excellent example of that dedication.

Key Points: 
  • "As the U.S. market's first and only human rabies immune globulin to be studied in children, KEDRAB is an excellent example of that dedication.
  • Today's news will provide added peace of mind for physicians who choose KEDRAB in treating children who have possibly been exposed to rabies.
  • We are especially proud of our partnership with Kamada, which has resulted in this significant step forward in global health."
  • "Kamada is excited to have a HRIGthat can treat peopleof all ages in the U.S. with the FDA-approved label expansion for KEDRAB," said Amir London, Chief Executive Officer of Kamada.

Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update, Confirming Safety and Effectiveness in Children

Retrieved on: 
Wednesday, June 2, 2021
Medical specialties, Infectious diseases, Clinical medicine, Neglected tropical diseases, Tropical diseases, Rabies, Viral encephalitis, Zoonoses, Kamada

The new updates to the KEDRAB label are based on data from the KEDRAB U .

Key Points: 
  • The new updates to the KEDRAB label are based on data from the KEDRAB U .
  • As the U.S. markets first and only human rabies immune globulin to be studied in children, KEDRAB is an excellent example of that dedication.
  • Todays news will provide added peace of mind for physicians who choose KEDRAB in treating children who have possibly been exposed to rabies.
  • We are especially proud of our partnership with Kamada, which has resulted in this significant step forward in global health.

Article - Travel safely with the EU Digital Covid Certificate

Retrieved on: 
Thursday, May 27, 2021
Medical specialties, Passports, Identity document, Medicine, Health, Medical records, Tropical diseases, World Health Organization, Immunology, Vaccination requirements for international travel, Travel restrictions related to the COVID-19 pandemic

How does the EU Digital Covid Certificate work?

Key Points: 
  • How does the EU Digital Covid Certificate work?
  • The certificate will make it easier for you to travel safely through the EU by showing that you have been vaccinated, had a negative test result or recovered from Covid-19 in the last six months.
  • The system will be in place for 12 months and cover all 27 EU countries as well as Iceland, Norway and Lichtenstein.
  • You dont have to have the certificate to travel - national requirements would then remain in place - but having it should make travelling easier.

Imhealthytoday Launches Vaccination Wallet

Retrieved on: 
Monday, May 24, 2021
Passports, Medical specialties, Vaccines, Medical records, Tropical diseases, World Health Organization, Vaccination, International Certificate of Vaccination or Prophylaxis, Medicine, Health

MIAMI, May 24, 2021 /PRNewswire/ --Imhealthytoday, a leading Covid-19 protection program headquartered in Miami, Florida, announces the launch of Vaccination Wallet, their latest screening tool now included in their program.

Key Points: 
  • MIAMI, May 24, 2021 /PRNewswire/ --Imhealthytoday, a leading Covid-19 protection program headquartered in Miami, Florida, announces the launch of Vaccination Wallet, their latest screening tool now included in their program.
  • Imhealthytoday is a turn-key complete solution combining proprietary screening and monitoring algorithms, integrated telehealth, expedited COVID-19 testing, contact tracing, population health status real-time reporting, visitor screening, on-site vaccination, surveillance testing, and now with the addition of the Vaccination Wallet tool; it offers secure real-time vaccination tracking.
  • The Vaccination Wallet is an innovative tool that enables Imhealthytoday members to digitally store their vaccination records eliminating the need to carry sensitive information.
  • In-depth vaccination information like vaccination certificates, date, dose stage, and renewal date will be available at the Population Health Status Dashboard.